MedTrace Logo

The Effect of Iloprost on Capillary Recruitment and Insulin Sensitivity in Type 2 Diabetes

NCT03380325 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-07-18

No results posted yet for this study

Summary

This study examines the effects of iloprost - a stable prostacyclin analogue - on insulin-mediated muscle capillary recruitment and whole-body glucose uptake in a cross-over design.

Conditions

  • Diabetes Mellitus, Type 2
  • Insulin Sensitivity/Resistance

Interventions

DRUG

Iloprost infusion

Iloprost is a stable prostacyclin analogue

Sponsors & Collaborators

  • Amsterdam UMC, location VUmc

    lead OTHER

Principal Investigators

  • Erik Serné, Dr. · Amsterdam UMC, location VUmc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-11
Primary Completion
2017-06-29
Completion
2017-06-29

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03380325 on ClinicalTrials.gov